{
    "title": "Pfizer boosts respiratory drug portfolio with ReViral purchase",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10695751/Pfizer-buy-RSV-drug-developer-ReViral-525-mln.html",
    "date": "2022-04-07",
    "keywords": [
        "deal",
        "rsv",
        "bhanvi",
        "satija",
        "virus",
        "acquisition",
        "candidate",
        "treatment",
        "pfizer",
        "analyst",
        "biopharma",
        "transaction",
        "inc",
        "thursday",
        "ltd",
        "worth",
        "milestone",
        "access",
        "drug",
        "portfolio",
        "takeover",
        "december",
        "respiratory",
        "coldlike",
        "cause",
        "pneumonia",
        "reviral",
        "pipeline",
        "product",
        "sisunatovir",
        "midstage",
        "vaccine",
        "care",
        "anderson",
        "chief",
        "officer",
        "hospital",
        "capital",
        "mampa",
        "activity",
        "ability",
        "return",
        "environment",
        "robyn",
        "reporting",
        "bengaluru",
        "editing",
        "soni",
        "syamnath"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}